![Colin Love](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Colin Love
Directeur/Membre du Conseil chez Replimune Ltd.
Fortune : 7 M $ au 30/06/2024
Postes actifs de Colin Love
Sociétés | Poste | Début | Fin |
---|---|---|---|
Replimune Ltd.
![]() Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Directeur/Membre du Conseil | 10/07/2017 | - |
Replimune (Ireland) Ltd.
![]() Replimune (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Replimune (Ireland) Ltd., part of Replimune Group, Inc., is a company headquartered in Dublin, Ireland. The firm provides professional, scientific and technical services. | Directeur/Membre du Conseil | 01/10/2019 | - |
Freeline Therapeutics Ltd.
![]() Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Colin Love
Anciens postes connus de Colin Love
Sociétés | Poste | Début | Fin |
---|---|---|---|
REPLIMUNE GROUP, INC. | Directeur des opérations | 01/10/2015 | 31/05/2024 |
Fondateur | 01/03/2015 | 31/05/2024 | |
FREELINE THERAPEUTICS HOLDINGS PLC | Directeur/Membre du Conseil | 11/03/2021 | 20/02/2024 |
Independent Dir/Board Member | 11/03/2021 | 20/02/2024 | |
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | 31/07/2015 |
AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/01/2011 | 01/01/2014 |
Corporate Officer/Principal | - | 01/01/2011 | |
BioVex Group, Inc.
![]() BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Corporate Officer/Principal | 15/10/2009 | 24/01/2013 |
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Corporate Officer/Principal | 15/05/2009 | 01/01/2011 |
░░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Colin Love
University of Glasgow | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 7 |
Etats-Unis | 5 |
Irlande | 2 |
Opérationnelle
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 8 |
Commercial Services | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
REPLIMUNE GROUP, INC. | Health Technology |
AMGEN INC. | Health Technology |
Entreprise privées | 8 |
---|---|
BioVex Ltd.
![]() BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Celltech Group Plc
![]() Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
BioVex, Inc.
![]() BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Group, Inc.
![]() BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
Replimune Ltd.
![]() Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Commercial Services |
Replimune (Ireland) Ltd.
![]() Replimune (Ireland) Ltd. Miscellaneous Commercial ServicesCommercial Services Replimune (Ireland) Ltd., part of Replimune Group, Inc., is a company headquartered in Dublin, Ireland. The firm provides professional, scientific and technical services. | Commercial Services |
Freeline Therapeutics Holdings Plc
![]() Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Freeline Therapeutics Ltd.
![]() Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Colin Love
- Expérience